Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|August 1, 1996
Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomasA Vacca, D Ribatti, M Fanelli, et al.
Transplantation|January 1, 1988
Synergy between subtherapeutic doses of cyclosporine and immunologic enhancement in rat recipients of cardiac allograftsW M Padberg, R H Lord, R Di Stefano, et al.
Clinical Chemistry|December 1, 1990
Increased circulating concentrations of interleukin 2 receptor during rejection episodes in heart- or kidney-transplant recipientsG C Zucchelli, A Clerico, R De Maria, et al.
Cellular Immunology|October 1, 1989
Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantationJ W Kupiec-Weglinski, G Mariani, K Tanaka, et al.
Journal of Hepatology|October 6, 2000
Combined treatment of relapse of chronic hepatitis C with high-dose alpha2b interferon plus ribavirin for 6 or 12 monthsV Di Marco, P Almasio, A Vaccaro, et al.
American Journal of Hematology|September 1, 1995
Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44A Vacca, M Di Loreto, D Ribatti, et al.
Journal of Viral Hepatitis|September 13, 2002
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon inductionV Di Marco, D Ferraro, P Almasio, et al.
European Journal of Haematology|August 1, 1994
Differential expression of two ICAM-1 epitopes and LFA-1 chains in B-cell non-Hodgkin's lymphomasA Vacca, G Ranieri, D Ribatti, et al.
International Journal of Antimicrobial Agents|November 25, 2000
Response-adjusted alpha-interferon therapy for chronic hepatitis C in HIV-infected patientsT Prestileo, G Mazzola, F Di Lorenzo, et al.
Transplantation|February 1, 1991
Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapyJ W Kupiec-Weglinski, T Sablinski, W W Hancock, et al.
Pageof 7